HPV Vaccination Shows Moderate Effectiveness in Women Aged 18-45 in China
A study found that HPV vaccination provides moderate protection against high-risk HPV DNA positivity in women aged 18-45 in China, with effectiveness increasing over time since vaccination.
Phase III
cervical cancer screening programs
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The study highlights the moderate effectiveness of HPV vaccination in adult women, which could influence vaccination uptake and public health strategies in China. This data is crucial for pharma companies to adjust their marketing and education efforts regarding HPV vaccines in this demographic.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor changes in vaccination rates and cervical cancer screening practices in response to this study's findings.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.